death
morpholog
commonli
known
apoptosi
result
posttransl
pathway
driven
larg
specif
limit
proteolysi
last
decad
structur
basi
apoptosi
regul
move
noth
quit
good
know
fundament
structur
exampl
initi
phase
premitochondri
regul
phase
execution
phase
inhibitor
antagonist
even
structur
substrat
field
well
advanc
best
known
proteolyt
pathway
coagul
cascad
fundament
new
mechan
proteas
regul
disclos
structur
evid
suggest
caspas
unusu
catalyt
mechan
activ
appar
unrel
event
depend
posit
apoptot
pathway
occupi
natur
occur
caspas
inhibitor
adopt
classic
inhibit
strategi
reveal
complet
novel
mechan
structur
mechanist
inform
appli
drive
therapeut
strategi
combat
overactiv
apoptosi
degen
diseas
underactiv
neoplasia
present
comprehens
review
caspas
regul
inhibitor
structur
mechanist
point
view
aim
consolid
mani
thread
defin
rapid
growth
field
death
morpholog
commonli
known
apoptosi
result
posttransl
pathway
driven
larg
specif
limit
proteolysi
last
decad
structur
basi
apoptosi
regul
move
noth
quit
good
know
fundament
structur
exampl
initi
phase
premitochondri
regul
phase
execution
phase
inhibitor
antagonist
even
structur
substrat
field
well
advanc
best
known
proteolyt
pathway
coagul
cascad
fundament
new
mechan
proteas
regul
disclos
structur
evid
suggest
caspas
unusu
catalyt
mechan
activ
appar
unrel
event
depend
posit
apoptot
pathway
occupi
natur
occur
caspas
inhibitor
adopt
classic
inhibit
strategi
reveal
complet
novel
mechan
structur
mechanist
inform
appli
drive
therapeut
strategi
combat
overactiv
apoptosi
degen
diseas
underactiv
neoplasia
present
comprehens
review
caspas
regul
inhibitor
structur
mechanist
point
view
aim
consolid
mani
thread
defin
rapid
growth
field
key
word
apoptosi
caspas
inhibitor
inhibitor
apoptosi
protein
iap
proteas
zymogen
life
pleasant
death
peac
transit
troublesom
isaac
asimov
two
group
simultan
report
ident
human
proteas
respons
activ
precursor
name
ice
enzym
sever
month
later
product
gene
govern
commit
apoptosi
caenorhabd
elegan
demonstr
show
ident
ice
public
initi
success
search
mani
group
ensu
year
mammalian
ice
homologu
govern
cell
death
today
call
proteas
caspas
constitut
famili
cystein
proteas
peptidas
employ
cystein
residu
catalyt
nucleophil
share
stringent
specif
cleav
substrat
aspart
acid
residu
target
protein
mammal
seven
caspas
probabl
involv
apoptosi
three
probabl
involv
proinflammatori
cytokin
activ
one
probabl
involv
keratinocyt
differenti
figur
first
structur
caspas
publish
display
novel
proteas
fold
famili
suggest
activ
mechan
structur
elucid
last
year
caspas
caspas
inhibitor
caspaseinhibitor
complex
support
earli
theori
caspas
catalyt
activ
overturn
mani
idea
caspas
activ
regul
review
focus
caspas
structurefunct
studi
last
year
set
context
current
concept
biolog
role
regul
cell
death
proinflammatori
cytokin
activ
sens
companion
excel
gener
review
publish
biochem
journal
gerri
cohen
caspas
constitut
famili
peptidas
clan
cd
defin
rawl
barrett
form
part
extens
abbrevi
use
alp
autoimmun
lymphoprolif
syndrom
apoptot
proteas
activ
ascpycard
apoptosisassoci
specklik
protein
contain
cardpydand
cardcontain
molecul
bir
baculovir
iap
repeat
cad
caspaseactiv
dnase
card
caspaserecruit
domain
carp
caspaseassoci
ring
protein
ced
cell
deathdefect
clarp
caspaselik
apoptosisregulatori
protein
craddraidd
domaincontain
adaptor
death
domainripassoci
protein
death
domain
crma
cytokin
respons
modifi
dd
death
domain
ded
death
effector
domain
dff
dna
fragment
factor
diablo
direct
iapbind
protein
low
pi
drosophila
inhibitor
apoptosi
disc
deathinduc
signal
complex
dronc
drosophila
caspas
fadd
fa
associ
via
death
domain
flice
faddlik
ice
flip
flice
inhibitori
protein
iap
inhibitor
apoptosi
protein
ibm
iap
bind
motif
icad
inhibitor
cad
ice
enzym
ipafclan
iceproteaseactiv
factorcard
lrr
nachtcontain
protein
lrr
leucinerich
repeat
nacht
ntpasedomain
name
naip
ciita
hete
nacht
lrr
pyrin
domain
contain
nbd
nucleotidebind
domain
nuclear
nod
nucleotidebind
oligomer
domaincontain
protein
parp
poli
adpribos
polymeras
pidd
protein
death
domain
rickcardiak
riplik
interact
clarp
kinasecardcontain
iceassoci
kinas
ring
realli
interest
new
gene
rip
receptorinteract
protein
serpin
serin
proteas
inhibitor
smac
second
mitochondri
activ
caspas
tfpi
tissu
factor
pathway
inhibitor
tlr
tolllik
receptor
tnf
tumour
necrosi
factor
tradd
via
death
domain
traf
tnf
receptorassoci
factor
trail
tnfrelat
apoptosisinduc
ligand
xlink
iapbaculovir
iap
repeatcontain
p
p
p
n
p
p
p
design
side
chain
substrat
inhibitor
nand
ctermin
direct
respect
p
p
scissil
peptid
bond
n
refer
cognat
pocket
proteas
accept
side
chain
email
pfuent
csicicccsantpau
email
gsalvesen
burnhamorg
human
caspas
group
accord
sequenc
similar
notic
sequenc
ident
divid
three
subfamili
accord
physiolog
distinct
inflammatori
initi
effector
caspas
contrast
widespread
distribut
famili
member
found
mainli
epidermi
may
involv
keratinocyt
differenti
activ
vivo
asp
residu
posit
matur
cleavag
site
given
p
aspart
residu
highlight
red
ital
case
usag
site
confirm
experiment
number
correspond
either
swissprot
entri
except
sequenc
commonli
express
isoform
given
system
use
throughout
work
colourcod
merop
peptidas
databas
reader
refer
http
meropssangeracuk
nomenclatur
committe
iubmb
place
enzym
categori
date
offici
classifi
clan
cd
famili
contain
distant
homologu
bacteri
plant
anim
kingdom
see
supplement
tabl
http
wwwbiochemj
caspas
found
strictli
metazoan
anim
earliest
identifi
member
nematod
term
caspas
well
recommend
definit
chain
assembl
introduc
literatur
divid
regard
terminolog
variou
structur
element
group
confusingli
use
design
differ
loop
differ
design
loop
exampl
defin
review
call
loop
loop
loop
loop
therefor
throughout
review
order
facilit
structur
comparison
employ
number
convent
caspas
catalyt
domain
somewhat
standard
solut
sort
problem
throughout
structur
biolog
insert
caspas
sequenc
compar
defin
letter
follow
insert
point
see
figur
howev
public
protein
data
base
entri
util
individu
caspas
number
attempt
satisfi
individu
tast
also
includ
number
thu
number
parenthes
use
refer
number
specif
particular
caspas
addit
includ
supplementari
data
pdb
file
convert
number
system
http
www
caspas
dimer
catalyt
domain
activ
state
use
prime
design
identifi
residu
symmetr
relat
unit
catalyt
cystein
one
domain
adjac
domain
function
dimer
exampl
unless
otherwis
state
individu
number
refer
human
protein
deposit
swissprot
databas
http
wwwexpasyorgsprot
aid
follow
sometim
cryptic
name
apoptot
protein
tabl
may
help
addit
list
abbrevi
proinflammatori
cytokin
store
cytosol
cell
await
proteolyt
activ
releas
releas
mechan
debat
resembl
known
secretori
mechan
proteolyt
mechan
due
least
part
transcriptiontranslationindepend
event
presum
act
rapid
respons
infect
extrem
benefici
part
innat
immun
cytokin
activ
caspas
could
simpli
defin
show
closest
sequenc
similar
intrins
substrat
specif
figur
human
equat
mice
equat
possibl
conundrum
sinc
import
residu
account
larg
defin
aspspecif
caspas
replac
ly
mice
human
gene
appear
express
proteas
major
popul
due
prematur
stop
codon
moreov
express
pattern
mous
differ
substanti
lessen
likelihood
particip
cytokin
activ
howev
immun
respons
endotoxin
lipopolysaccharid
attenu
individu
express
fulllength
enzym
thu
increas
risk
develop
sepsi
genet
data
link
cytokin
activ
mice
biochem
data
link
human
possibl
mechan
interest
dual
requir
human
orthologu
mous
cytokin
process
describ
later
apoptot
caspas
initi
effector
depend
point
entri
apoptot
pathway
initi
caspas
first
activ
particular
death
pathway
figur
supplement
figur
http
wwwbiochemjorg
constitut
open
step
minim
twostep
cascad
activ
effector
caspas
one
characterist
initi
presenc
homotyp
card
caspaserecruit
domain
ded
death
effector
domain
interact
domain
ntermini
figur
modul
direct
procaspas
oligomer
activ
assembl
cell
perhap
import
characterist
initi
inher
substrat
specif
explain
thornberri
colleagu
allow
recogn
target
effector
caspas
figur
human
mice
recogn
two
independ
initi
pathway
extrins
pathway
defin
activ
via
transmembran
receptor
tnf
tumour
necrosi
factor
typei
receptor
famili
intrins
pathway
respond
stress
genotox
damag
development
cue
activ
figur
human
contain
close
rel
name
absent
mice
activ
within
oligomer
assembl
directli
activ
effector
strictli
conserv
residu
shown
white
red
background
conserv
residu
grey
background
singlenucleotid
polymorph
indic
bold
ital
residu
involv
substrat
recognit
catalysi
mark
residu
repres
autolyt
cleavag
site
intersubunit
linker
red
cystein
residu
form
dimer
interfac
disulphid
orang
activ
autolysi
cleavag
site
detect
vivo
presum
anoth
cellular
proteas
residu
mutat
bold
blue
letter
ser
residu
reportedli
phosphoryl
shadow
yellow
secondari
structur
represent
arrow
cylind
follow
catch
classif
http
wwwbiochemuclacukbsmcath
apoptot
effector
defin
absenc
recogniz
homotyp
recruit
domain
figur
togeth
respons
major
limit
proteolyt
event
combin
creat
morpholog
cellular
chang
known
apoptosi
close
relat
virtual
indistinguish
substrat
inhibitor
specif
largest
differ
effector
ntermin
peptid
region
thought
involv
subcellular
target
death
signal
ligandenforc
cluster
receptor
cell
surfac
lead
activ
initi
caspas
directli
cleav
activ
effector
possibl
predominantli
respons
limit
proteolysi
character
apoptot
morpholog
cell
hand
genotox
damag
transmit
mechan
thought
involv
releas
cytochrom
c
mitochondria
engag
effector
caspas
latter
event
progress
initi
activ
platform
common
execut
phase
regul
direct
caspas
inhibit
xiap
also
regul
activ
form
xiap
influenc
antagonist
protein
smacdiablo
compet
caspas
iap
final
iap
antagonist
may
sequest
iap
mliap
melanoma
iap
act
competit
sink
avail
proapoptot
antagonist
although
modul
may
regul
apoptot
pathway
cellspecif
manner
framework
consid
common
mammalian
cell
diverg
complet
frequent
consid
effector
base
short
ntermin
peptid
inher
substrat
specif
differ
substanti
see
suggest
nonoverlap
subset
natur
substrat
variou
data
implic
execut
phase
howev
data
may
truli
repres
studi
much
frequent
two
possibl
role
develop
demonstr
genet
ablat
certain
mice
strain
genet
ablat
caspas
instruct
help
place
hierarch
scheme
portray
figur
anim
ablat
defici
cytokin
process
without
overt
development
apoptot
phenotyp
contrast
phenotyp
apoptot
caspas
knockout
gross
evid
antiapoptot
vari
earli
embryon
lethal
perinat
lethal
rel
mild
eg
defect
process
normal
oocyt
ablat
current
mice
ablat
without
known
development
phenotyp
care
taken
equat
lack
development
phenotyp
less
import
physiolog
role
influenc
strain
background
exampl
genet
background
null
mice
uniformli
affect
sever
perinat
lethal
neurodevelopment
phenotyp
character
massiv
expans
neuron
progenitor
cell
forebrain
consist
fail
apoptosi
stark
contrast
background
null
mice
reach
adulthood
minim
neuron
phenotyp
origin
mean
mark
strain
depend
unclear
argu
caution
ascrib
function
caspas
base
simpli
development
phenotyp
sometim
role
develop
correl
patholog
phenotyp
exampl
mice
phenotyp
character
excess
oocyt
due
inhibit
cell
delet
develop
nervou
system
mice
seem
unaffect
howev
experi
explant
primari
neuron
suggest
programm
death
induc
trophic
factor
withdraw
null
mice
role
subsum
thu
exist
degre
compens
redund
emphas
studi
complic
assess
caspas
physiolog
role
use
mice
genet
answer
simpli
complex
mani
current
interpret
one
conclud
role
individu
caspas
straindepend
cell
typedepend
even
contextdepend
given
contradict
observ
mous
caspas
knockout
use
gain
insight
lesson
learn
human
caspas
defici
human
mutat
f
code
sequenc
report
exhibit
alp
autoimmun
c
biochem
societi
lymphoprolif
syndrom
caus
defect
lymphocyt
apoptosi
associ
mutat
alp
support
data
predict
homozygos
frequenc
mutat
approx
danish
popul
thu
argu
major
contribut
alp
phenotyp
human
mutant
w
also
exhibit
defect
lymphocyt
apoptosi
pronounc
defect
abil
activ
lymphocyt
result
immunodefici
significantli
latter
studi
suggest
defici
compat
develop
human
although
embryon
lethal
mice
taken
togeth
studi
suggest
although
major
overlap
redund
probabl
distinct
function
tcell
subset
current
data
role
caspas
neurodegen
diseas
confus
even
contradictori
review
examin
postmortem
tissu
implic
caspas
multipl
neurodegen
diseas
whether
activ
apoptosi
repres
caus
degener
mere
dispos
alreadi
dysfunct
neuron
remain
establish
respect
distinct
made
chronic
neurodegen
diseas
alzheim
huntington
parkinson
exampl
acut
one
nerv
crush
injuri
stroke
difficulti
construct
anim
model
human
neurodegen
diseas
make
assess
caspas
particip
apoptosi
difficult
chronic
diseas
definit
note
acut
case
good
evid
neuron
brain
spare
specif
caspas
knockout
ablat
caspas
activ
review
bode
well
anticaspas
therapi
mean
spare
acut
damag
neuron
therebi
give
chanc
recov
follow
injuri
flip
side
inappropri
apoptosi
lead
degen
diseas
role
caspas
prolif
diseas
especi
cancer
exampl
silenc
human
gene
frequent
associ
neuroblastoma
give
support
concept
apoptot
caspas
tumour
suppressor
gener
signal
drive
cell
prolifer
also
prime
apoptot
machineri
inher
propens
rapidli
cycl
cell
secur
cell
expans
locat
govern
specif
cellcel
interact
cell
exceed
local
interact
environ
die
process
known
anoiki
stem
loss
cellcel
contact
tumour
cell
must
adapt
inactiv
apoptot
forc
would
normal
signal
demis
clear
signific
event
mani
possibl
neoplast
transform
lead
cancer
inactiv
apoptosi
one
sever
control
point
apoptot
pathway
review
therefor
therapeut
measur
design
interven
restor
apoptot
process
potenti
specif
anticanc
agent
inde
mani
chemotherapeut
pharmaceut
work
induc
apoptosi
tumour
cell
specif
intervent
ablat
known
anticaspas
control
caus
regress
tumour
vivo
trick
usual
target
achil
heel
cancer
cell
way
caus
apoptosi
nontumour
prolifer
cell
popul
sinc
pioneer
work
structur
sever
crystal
structur
inflammatori
initi
effector
caspas
report
tabl
section
discuss
major
characterist
caspas
fold
basi
understand
subsequ
section
fundament
catalyt
domain
seen
caspas
structur
compris
larg
kda
small
kda
subunit
oblig
catalyt
domain
compos
larg
small
subunit
tightli
pack
compact
ellipsoid
approxim
dimens
twofold
axi
case
constitut
exact
crystallograph
axi
relat
pair
catalyt
domain
figur
activ
caspas
refer
homodim
heterodim
describ
later
initi
caspas
requir
proteolyt
process
achiev
activ
form
somewhat
confus
terminolog
replac
review
concept
catalyt
domain
often
compos
two
subunit
chain
catalyt
domain
deriv
singl
procaspas
molecul
see
compos
twist
mostli
parallel
sandwich
two
layer
see
figur
schemat
topolog
diagram
two
domain
fit
togeth
align
ctermin
strand
antiparallel
manner
figur
thu
gener
continu
caspas
fold
caspasehaemoglobinas
fold
defin
conserv
bacteri
rel
gingipain
r
predict
number
distantli
relat
proteas
summar
supplement
protein
addit
catalyt
domain
inflammatori
initi
caspas
carri
ntermini
one
two
copi
card
ded
modul
figur
critic
activ
vivo
despit
lack
obviou
sequenc
similar
card
ded
dd
death
domain
found
exampl
fa
pyrindapin
domain
apoptosi
interferon
respons
domain
identifi
adaptor
protein
nacht
ntpasedomain
name
naip
ciita
hete
lrr
leucinerich
repeat
pyrin
domaincontain
share
common
fold
globular
domain
mainli
compos
six
antiparallel
helic
build
greek
key
structur
similar
thu
strongli
suggest
common
evolutionari
origin
member
socal
dd
death
superfamili
compar
structur
analysi
recruit
domain
review
previous
activ
site
enzym
open
structur
commonli
found
topolog
switch
point
ie
posit
within
close
ctermin
end
central
loop
origin
two
adjac
lead
opposit
helic
layer
locat
switch
point
thu
deriv
topolog
diagram
first
appreci
structur
see
also
figur
gener
rule
valid
also
caspas
sinc
catalyt
residu
locat
loop
connect
front
helix
neighbour
strand
follow
back
helix
back
front
refer
standard
caspas
orient
shown
figur
loop
harbour
one
residu
determin
characterist
p
specif
although
less
obviou
activ
caspas
similar
consider
appli
second
residu
catalyt
dyad
found
larg
highli
variabl
linker
figur
loop
protrud
strand
termin
anoth
conserv
substratebind
residu
toward
front
helic
layer
one
eman
adjac
strand
lead
back
helix
figur
final
loop
contain
second
arginin
residu
involv
substrat
fixat
see
also
ident
catalyt
residu
confirm
mutagenesi
studi
accompani
determin
crystal
structur
ensu
year
alas
mutant
caspas
gener
shown
essenti
inact
vitro
note
mutant
initi
caspas
confer
domin
neg
apoptot
phenotyp
overexpress
multipl
cell
line
see
exampl
mutat
topolog
equival
cy
residu
legumain
separin
abrog
catalysi
distant
rel
caspas
final
coval
linkag
atom
substratelik
tetrapeptid
inhibitor
crystal
structur
human
crystal
structur
human
exemplifi
fundament
caspas
fold
shown
bound
tetrapeptid
aldehyd
inhibitor
acetylilegluthraspcho
pdb
entri
repres
highestresolut
structur
caspas
report
date
note
threelay
structur
twist
sandwich
interdomain
contact
area
built
central
small
subunit
addit
interact
characterist
loop
bundl
tie
togeth
cand
ntermini
larg
small
subunit
neighbour
domain
bound
inhibitor
repres
ballandstick
model
dithian
diol
molecul
trap
cleft
two
monom
term
central
caviti
obviou
reason
b
simplifi
topolog
diagram
caspas
structur
follow
catch
definit
secondari
structur
element
addit
ntermin
variabl
length
shown
present
close
bottom
barrel
also
depict
addit
found
sole
long
posit
catalyt
dyad
residu
red
along
specificitydetermin
arginin
residu
indic
locat
loop
contain
import
function
element
indic
blue
text
use
number
convent
design
throughout
review
along
altern
design
conclus
establish
latter
residu
activesit
nucleophil
see
also
figur
anoth
critic
element
catalyt
machineri
divers
proteolyt
enzym
oxyanion
hole
pocket
hydrogenbond
carbonyl
oxygen
p
residu
substrat
catalysi
concept
oxyanion
hole
propound
trypsinlik
serin
proteas
compris
mainchain
nitrogen
atom
residu
recent
timeresolv
crystallograph
studi
molecular
dynam
simul
calcul
base
combin
quantum
mechanicalmolecular
mechan
approach
underscor
critic
role
catalysi
particular
hydrogen
bond
donat
amid
group
crystal
structur
methyl
ketoneinhibit
caspas
reveal
oxyanion
hole
consist
backbon
nitrogen
atom
strictli
conserv
catalyt
thu
similar
trypsinlik
enzym
figur
avail
crystal
structur
member
three
caspas
subfamili
bound
highli
similar
substrateanalogu
peptidyl
inhibitor
tabl
allow
detail
comparison
specif
determin
seen
effect
analysi
interact
inhibitor
acetylaspgluvalaspcho
caspas
among
proteas
stringent
specif
p
residu
remark
pocket
almost
ident
construct
side
chain
strictli
conserv
residu
figur
deep
highli
basic
pocket
ideal
shape
accommod
aspart
side
chain
explain
four
order
magnitud
lower
catalyt
effici
cleavag
peptid
glutam
significantli
mous
contain
ly
posit
equival
residu
lessen
likelihood
catalyt
effici
caspas
subsit
also
contribut
substrat
differenti
notabl
aromat
pocket
form
side
chain
preferenti
accommod
small
aliphat
residu
ala
val
contrast
subsit
larger
inflammatori
initi
caspas
due
substitut
val
ala
therefor
toler
well
residu
bulkier
side
chain
pocket
site
show
consider
alter
substrat
bind
unoccupi
activ
site
side
chain
occupi
pocket
bind
tetrapeptid
inhibitor
side
chain
rotat
around
bond
allow
occup
pocket
degre
plastic
confirm
recent
studi
inhibitor
bind
interestingli
analog
rotat
complet
unrel
serin
proteas
factor
ixa
occur
substrat
bind
open
pocket
case
factor
ix
prevent
prematur
onset
blood
coagul
current
function
ascrib
rotat
residu
play
dual
role
anchor
substrat
peptidyl
inhibitor
addit
role
pocket
perhap
importantli
engag
mainchainmainchain
hydrogen
bond
p
residu
secondli
guanidinium
group
interact
carboxyl
p
glutam
explain
prefer
residu
small
peptid
substrat
inhibitor
adjac
basic
residu
allow
tighter
bind
inhibitor
contain
glutam
acid
residu
posit
p
although
without
direct
salt
bridg
format
inde
show
weaker
k
valu
inhibit
benzyloxycarbonylalavalaspcho
compar
benzyloxycarbonylgluvalaspcho
wherea
show
discrimin
two
aldehyd
inhibitor
subsit
similar
charact
caspas
pocket
provid
major
specificityconf
element
differ
subclass
inflammatori
predict
subsit
extend
shallow
hydrophob
depress
best
accommod
larg
aromat
side
chain
particular
indol
moieti
p
trp
residu
engag
multipl
interact
residu
interact
explain
inflammatori
caspas
optim
process
substrat
trpgluxaaasp
sequenc
xaa
denot
amino
acid
residu
base
specif
proteas
classifi
group
caspas
contrast
onetoon
correspond
group
inflammatori
caspas
less
clearcut
distinct
initi
effector
caspas
base
prefer
cleavag
sequenc
initi
classif
group
ii
preferenti
cleav
aspgluxaaasp
group
iii
specif
leuilevalgluxaaasp
caspas
challeng
observ
toler
equal
well
small
hydrophob
ile
acid
asp
residu
p
apoptot
caspas
possess
bulki
trp
residu
posit
compar
smaller
ilev
found
figur
reduc
consider
size
pocket
indol
moieti
residu
contribut
prefer
short
branch
aliphat
side
chain
group
iii
caspas
van
der
waal
contact
also
hydrogenbond
carboxyl
p
aspart
residu
addit
van
der
waal
polar
interact
strengthen
recognit
chemic
divers
group
p
hydrophob
side
chain
exampl
contact
aromat
side
chain
observ
altern
p
aspart
interact
carboxyamid
also
noteworthi
similar
insert
residu
posit
compar
figur
gener
enlarg
loop
flap
narrow
pocket
presenc
flap
could
partial
explain
increas
discrimin
asp
glu
p
respect
interestingli
suggest
phosphoryl
flap
may
downregul
activ
effector
caspas
closeup
activesit
region
acetylaspvalalaaspmethyl
ketoneinhibit
pdb
code
shown
standard
orient
ie
activesit
residu
face
viewer
substrat
run
left
right
stereo
plot
display
ribbon
represent
caspas
larg
subunit
blue
small
subunit
red
b
grasp
electrostat
surfac
potenti
caspas
contour
k
b
e
stick
inhibitor
import
residu
label
panel
hydrogen
bond
calcul
use
hbplu
http
wwwbiochemuclacukbsmhbplushomehtml
indic
orang
dot
line
note
inhibitor
bind
extend
conform
backbon
atom
p
p
residu
hydrogenbond
strictli
highli
conserv
caspas
residu
guanidinium
group
engag
strong
salt
bridg
carboxyl
p
aspart
hydrogenbond
sidechain
carboxyamid
combin
extend
hydrogen
bond
enzym
substrat
recognit
base
mainli
interact
pocket
place
caspas
mechanist
sens
closer
serin
proteas
particular
subtilisin
clan
c
propos
substratehydrolysi
mechanist
scheme
acyl
step
carbonyl
oxygen
noncoval
bound
p
residu
anchor
hydrogen
bond
nitrogen
atom
oxyanion
hole
increas
polar
co
bond
therefor
facilit
nucleophil
attack
sulphur
atom
highli
electrophil
carbonyl
carbon
result
coval
enzymesubstr
adduct
highenergi
tetrahedr
intermedi
visual
crystal
structur
methyl
ketoneinhibit
caspas
see
imidazol
moieti
act
gener
acid
stage
catalysi
proton
group
leav
peptid
product
thu
avoid
reform
peptid
bond
deacyl
acylenzym
complex
occur
similar
manner
deproton
side
chain
abstract
proton
water
molecul
hydrolyt
water
thu
activ
attack
thioester
bond
deacyl
proce
second
tetrahedr
intermedi
form
upon
nucleophil
attack
hydroxi
group
carbonyl
carbon
put
neutral
gemdiol
intermedi
found
recent
quantum
mechanicsmolecular
mechan
simul
hydrolysi
acylenzym
complex
shown
grey
atom
parenthes
author
also
predict
catalyt
histidin
activ
hydroxi
group
residu
conserv
caspas
ruptur
c
bond
regener
enzym
noncoval
complex
ntermin
peptid
product
analog
serin
proteas
conceiv
movement
loop
coupl
latter
reaction
thu
allow
disrupt
mainchainmainchain
hydrogen
bond
p
p
residu
p
carbonyl
oxygen
atom
oxyanion
hole
word
thioester
hydrolysi
product
releas
may
synchron
ensur
high
effici
catalysi
current
except
requir
occupi
subsit
effici
substrat
cleavag
contrast
presenc
p
residu
confer
increas
catalyt
effici
may
least
partli
reflect
better
burial
p
aspart
origin
extend
specif
unveil
recent
solv
highresolut
structur
complex
acetylleuaspgluseraspcho
p
leu
side
chain
occupi
small
groov
form
two
residu
thu
explain
prefer
small
hydrophob
residu
posit
prime
subsit
recent
character
crystallograph
appear
less
restrict
pocket
systemat
studi
use
fluoresc
peptidyl
substrat
howev
indic
clear
degre
discrimin
small
gli
ala
ser
residu
posit
p
caspas
test
larg
aromat
side
chain
phetyr
also
well
toler
polar
residu
prolin
observ
verifi
extend
previou
investig
p
substrat
specif
neither
experiment
investig
use
timeresolv
crystallographi
detail
theoret
calcul
substrat
cleavag
report
caspas
recent
quantum
mechanicsmolecular
mechan
studi
deacyl
reaction
see
howev
similar
chemic
group
involv
catalysi
crystal
structur
activ
caspas
bound
substratelik
inhibitor
suggest
similar
cours
catalyt
reaction
serin
proteas
famili
cystein
proteas
summar
figur
altern
role
atom
stabil
develop
charg
leav
group
propos
bradi
cowork
author
postul
water
molecul
hydrogenbond
amid
seen
directli
crystal
structur
donat
proton
leav
amin
group
mechan
thu
practic
revers
role
classic
oxyanion
hole
controversi
spur
distinguish
characterist
caspas
compar
serin
proteas
cystein
proteas
clan
side
chain
second
compon
catalyt
dyad
locat
away
atom
clearli
unusu
distanc
accept
thiol
proton
impli
may
prepolar
nucleophil
may
develop
along
reaction
coordin
accord
ph
optima
caspas
lie
narrow
rang
substrateinduc
activ
crystal
structur
noninhibit
unligand
featur
displac
approx
activ
posit
activesit
cleft
partial
invad
residu
therefor
author
suggest
substrat
bind
induc
final
step
activesit
format
contrast
crystal
structur
uninhibit
show
arrang
catalyt
residu
seen
inhibitorbound
form
see
also
discuss
caspas
activ
whether
latent
conform
observ
free
specif
caspas
current
unknown
stabl
intermedi
zymogen
enzym
fulli
develop
activ
site
uncommon
proteas
class
might
highli
popul
effector
caspas
solut
issu
refer
possibl
particip
carbonyl
oxygen
residu
import
element
catalyt
machineri
first
propos
wilson
colleagu
later
other
oxygen
atom
accept
hydrogen
bond
atom
might
either
affect
basic
imidazol
moieti
andor
orient
similarli
carboxyl
trypsinlik
proteas
side
chain
catalyt
asnasp
residu
clan
ca
cystein
peptidas
regardless
noteworthi
investig
role
third
residu
clan
ca
cystein
proteas
papain
reveal
compar
minor
role
catalysi
hydrolys
tetrapeptid
pnitroanilid
substrat
low
k
cat
approx
similar
valu
report
mutant
catalyt
aspart
papain
carboxyl
p
residu
might
also
help
orient
catalysi
propos
wilson
cowork
final
hisci
catalyt
dyad
report
sever
viral
proteas
notwithstand
lower
distanc
although
case
also
involv
third
residu
disput
heurist
consider
may
brought
either
support
refut
role
carbonyl
group
residu
catalysi
attract
consider
favour
possibl
direct
engag
peptid
bond
cleavag
might
allow
better
connect
product
releas
exampl
weaken
interact
neighbour
side
chain
p
residu
rigor
quantum
mechanicsmolecular
dynam
calcul
along
structur
mutagenesi
studi
need
settl
issu
discuss
final
character
caspas
catalyt
mechan
common
occurr
sequenc
match
prefer
inher
substrat
specif
caspas
intracellular
protein
would
suggest
multitud
substrat
vivo
somewher
order
sever
hundr
inde
list
protein
cleav
caspas
either
vivo
vitro
ever
grow
detail
analysi
caspas
substrat
see
howev
protein
rigor
establish
biolog
relev
bona
fide
death
substrat
mani
may
repres
innoc
bystand
reader
refer
review
specif
detail
mani
put
natur
caspas
substrat
cover
overal
concept
enzym
region
locat
distant
activ
site
particip
substrat
bind
exosit
essenti
determin
substrat
recognit
process
regulatori
proteas
notabl
involv
blood
coagul
matrix
regul
therefor
remark
similar
exosit
identifi
far
caspas
although
propos
explain
discrep
cleavag
prefer
vitro
substrat
cleavag
site
actual
found
particular
larg
number
substrat
process
noncanon
site
find
impli
exosit
caspas
recogn
specif
tertiari
motif
substrat
addit
case
overrul
specif
requir
deriv
studi
short
synthet
peptid
support
recent
investig
reveal
caspas
recognit
natur
inhibitor
might
also
reli
exosit
interact
see
hand
conceiv
solventexpos
disord
loop
present
nonoptim
cleavag
sequenc
might
process
activ
caspas
without
need
addit
interact
instanc
heatdenatur
cleav
effici
fold
precursor
finish
overview
caspas
activ
briefli
discuss
three
protein
substrat
whose
cleavag
repeatedli
associ
execut
program
cell
death
discuss
next
section
import
substrat
caspas
zymogen
proapoptot
famili
member
bid
earli
substrat
cleav
protein
transloc
rapidli
mitochondria
process
bid
engag
two
proapoptot
member
bax
bak
hypothes
select
permeabil
mitochondri
membran
amplifi
death
signal
transmit
fasfasl
mitochondri
level
solut
structur
bid
show
cleavag
site
map
unusu
long
highli
flexibl
loop
therefor
scissil
bond
could
easili
target
p
p
residu
conform
inher
substrat
specif
short
peptidyl
substrat
vitro
see
notabl
vitrotransl
bid
target
site
activ
make
activesiteonli
specif
arguabl
case
cleav
second
site
found
loop
ctermin
site
certainli
access
target
cytotox
serin
proteas
granzym
b
unleash
mitochondri
pathway
via
similar
baxbakmedi
mechan
importantli
second
site
almost
ident
activ
cleavag
site
intersubunit
linker
figur
thu
tempt
specul
import
exositemedi
interact
preferenti
guid
site
bid
activesit
cleft
convers
steer
caspas
away
site
recombin
variant
bid
mutat
swap
cleavag
site
might
help
clarifi
point
final
clear
cleavag
long
flexibl
loop
bid
lie
helic
would
lead
conform
chang
analog
famili
member
remov
helix
gel
filtrat
analysi
reveal
vitro
least
helix
even
dissoci
cleav
bid
uncertainti
function
consequ
bid
cleavag
internucleosom
dna
fragment
visual
form
dna
ladder
hallmark
cell
undergo
apoptosi
nucleas
respons
doublestrand
cleavag
dna
fragment
factor
cad
caspaseactiv
dnase
exist
tight
noncoval
complex
endogen
chaperon
inhibitor
inhibitor
cad
complex
disrupt
cleav
posit
linker
ntermin
central
domain
locat
ctermin
domain
allow
free
nucleas
dimer
catalyt
compet
form
cleavag
site
thu
map
presum
highli
flexibl
expos
linker
may
well
access
without
need
addit
enzymesubstr
interact
solut
structur
domain
bound
homolog
ntermin
domain
isol
domain
report
howev
case
bid
difficult
understand
sever
two
poorli
order
loop
probabl
contact
lead
dissoci
result
fragment
nucleas
possibl
cleavag
serv
convert
firstord
interact
secondord
one
although
kinet
event
remain
clarifi
larg
complementari
interfac
ntermin
domain
two
moieti
reveal
solut
structur
infer
multipl
observ
independ
interfac
catalyt
domain
domain
inhibitor
exampl
recombin
fragment
strong
repressor
nucleas
activ
show
lower
affin
fulllength
furthermor
truncat
natur
variant
chaperon
lack
fold
ctermin
domain
bind
strongli
fulllength
form
remark
singl
point
mutat
charg
interfac
residu
ntermin
domain
disrupt
complex
format
recent
crystal
structur
activ
report
featur
zn
mediat
dimer
author
also
report
central
domain
critic
inhibitori
activ
reliev
caspasemedi
cleavag
due
low
affin
isol
domain
enzym
although
kinet
dissoci
yet
explain
mention
thu
mechan
inhibit
icad
basic
reli
enzym
monomer
curious
similar
principl
appli
inhibit
physiolog
inhibitor
xiap
xlink
iap
inhibitor
apoptosi
protein
see
abund
nuclear
enzym
parp
poli
adpribos
polymeras
catalys
attach
poli
adpribos
sever
acceptor
protein
includ
respons
dna
strand
break
parp
cleavag
site
bisect
bipartit
nuclear
local
signal
result
form
synthes
adpribos
polym
respons
damag
dna
parp
one
first
identifi
exampl
substrat
process
effector
caspas
much
effici
either
inflammatori
initi
notwithstand
fact
parp
cleavag
site
perfectli
match
substrat
specif
effector
caspas
secondari
interact
seem
modul
process
vivo
inde
parp
molecul
modifi
long
branch
poli
adpribos
chain
possess
much
higher
affin
close
homologu
vivo
thu
revers
observ
catalyt
effici
caspas
small
synthet
substrat
enhanc
affin
result
specif
interact
larg
subunit
poli
adpribos
notabl
potenti
acceptor
poli
adpribos
closest
ie
locat
almost
amino
acid
residu
downstream
cleavag
site
although
caspas
thought
exquisit
select
asp
pocket
transcript
factor
max
cleav
noncanon
site
follow
dephosphoryl
case
neg
effect
protein
modif
might
explain
unfavour
contact
phosphoryl
moieti
attach
p
residu
enzym
pocket
howev
worth
mention
cleav
peptid
compris
max
residu
suggest
tertiaryquaternari
structur
properli
fold
transcript
factor
respons
use
atyp
site
particular
max
homodimer
presenc
residu
ctermin
cleavag
site
amino
acid
appear
import
proteolysi
find
discuss
among
other
illustr
exosit
interact
addit
contact
residu
immedi
surround
p
p
scissil
bond
modul
caspas
specif
macromolecular
substrat
inspect
caspas
structur
see
figur
would
suggest
characterist
loopbundl
also
residu
distant
helic
neighbour
monom
may
provid
addit
substrat
recognit
surfac
unregul
caspas
activ
would
lethal
cell
prevent
occurr
cell
store
caspas
latent
precursor
zymogen
procaspas
requir
activ
event
recent
advanc
suggest
activ
mechan
initi
effector
caspas
entir
distinct
devic
stabil
latent
zymogen
fundament
conserv
although
detail
activ
pathway
yet
fulli
work
establish
activ
initi
apoptot
caspas
probabl
also
inflammatori
caspas
requir
dimer
inact
monomer
proform
occur
vivo
upon
recruit
larg
macromolecular
assembl
call
activ
platform
supplement
figur
http
stark
contrast
initi
zymogen
effector
exist
within
cytosol
inact
dimer
activ
limit
proteolysi
within
intersubunit
linker
carri
initi
caspas
occasion
proteas
specif
circumst
crystal
structur
initi
structur
zymogen
activ
inhibitorbound
serv
model
ration
appar
dichotomi
dimer
mechan
initi
caspas
activ
cleavag
mechan
effector
caspas
activ
addit
sever
investig
address
activ
biochem
character
particular
activationmatur
mechan
inflammatori
initi
caspas
extens
structur
dataset
start
analysi
activ
process
effector
caspas
two
major
mechan
zymogen
proteolyt
enzym
kept
latent
conform
convert
rapidli
activ
enzym
upon
cleavag
usual
singl
peptid
bond
simplest
conceiv
situat
catalyt
machineri
preform
prodomain
steric
block
substrat
access
observ
instanc
sever
metalloproteas
subtilisinlik
serin
proteas
clan
ca
cystein
proteas
review
second
mechan
typic
trypsinlik
proteas
involv
insert
ntermin
peptid
liber
upon
activ
cleavag
main
bodi
enzym
stabil
catalyt
compet
conform
review
origin
result
associ
two
monomer
fold
intermedi
monomer
domain
extrem
tightli
associ
dimer
probabl
true
close
homologu
coeffector
crystal
structur
show
domain
organ
zymogen
overal
constitut
secondari
structur
element
indistinguish
activ
enzym
furthermor
residu
form
catalyt
dyad
displac
slightli
zymogen
displac
disrupt
oxyanion
hole
particular
howev
evid
structur
differ
activ
singlechain
zymogen
relat
critic
determin
substrat
specif
protrud
bulk
solvent
figur
loop
disord
zymogen
strike
contrast
welldefin
conform
inhibitorbound
caspas
disord
particularli
affect
crucial
residu
contact
substrat
residu
posit
p
p
also
neighbour
shape
pocket
activ
caspas
see
figur
locat
bottom
pocket
slightli
displac
conform
observ
inhibitorbound
caspas
flap
includ
side
chain
disord
altogeth
substratebind
pocket
two
monom
essenti
disrupt
explain
complet
lack
catalyt
activ
activ
mechan
effector
caspas
thu
appear
close
relat
trypsinlik
serin
proteas
superposit
structur
activ
enzym
immedi
reveal
partial
insert
intersubunit
linker
central
caviti
account
unexpect
expuls
substratebind
loop
linker
inconform
allow
characterist
adopt
conform
observ
activ
caspas
compar
figur
particular
would
major
clash
residu
iv
elbow
loop
insert
linker
neighbour
monom
note
two
independ
crystal
structur
determin
use
crystal
grown
rather
differ
solut
show
differ
extent
insert
linker
peptid
thu
two
linker
compet
elbow
loop
occup
central
caviti
conform
reveal
crystal
structur
repres
snapshot
particularli
stabl
conform
linker
region
almost
certainli
dynam
motion
limit
size
central
caviti
figur
accommod
two
linker
simultan
impli
dimer
intrins
asymmetr
major
differ
symmetr
arrang
domain
activ
caspas
see
compar
figur
consequ
symmetri
break
mechan
activ
particular
frustrat
state
linker
uncleav
zymogen
explor
far
cleavag
site
promot
releas
intersubunit
linker
central
caviti
contact
newli
form
nand
ctermini
small
larg
subunit
neighbour
domain
stabil
activ
enzym
conform
form
bundl
net
free
energi
gain
provid
loopbundl
format
seem
prevent
ntermini
small
subunit
slide
back
central
caviti
line
recent
theoret
analysi
residu
contribut
dimer
closeup
interdomain
interfac
left
surfac
middl
caviti
depth
right
b
acetylaspgluvalaspchoinhibit
form
pdb
acetylilegluthraspchoinhibit
form
pdb
sever
interdomain
residu
shown
nonhydrogen
atom
colourcod
hydrogen
bond
denot
orang
dot
line
central
caviti
form
dimer
interfac
significantli
larger
attend
possibl
intersubunit
linker
would
zymogen
therefor
visibl
may
partial
occupi
without
produc
steric
clash
seen
smaller
central
caviti
stabil
interestingli
chang
zymogen
activ
conform
revers
bind
small
molecul
central
caviti
activ
conform
act
inhibit
proteas
alloster
mechan
alloster
inhibitor
support
import
translat
organ
loop
bundl
form
activ
impli
central
caviti
caspas
altern
target
activ
site
small
molecul
target
drug
design
puzzl
observ
made
crystal
structur
cleav
uninhibit
linker
peptid
remain
partial
insert
central
caviti
thu
impair
format
fulli
compet
activ
site
contrast
catalyt
machineri
almost
perfectli
arrang
correspond
structur
import
except
see
supplement
movi
http
perhap
high
salt
concentr
use
grow
crystal
free
disrupt
interact
newli
form
chain
termini
favour
pseudozymogen
conform
instead
whatev
reason
observ
might
underscor
fundament
correl
linker
insert
catalyt
state
caspas
also
note
possibl
activ
effici
vitro
treatment
serin
proteas
cathepsin
g
process
zymogen
two
residu
upstream
physiolog
cleavag
site
find
indic
cleavag
particular
asp
residu
need
activ
notabl
differ
activ
mechan
trypsinlik
serin
proteas
final
recal
biochem
data
place
downstream
caspas
apoptosi
least
cell
type
appear
necessari
remov
ntermin
peptid
initi
caspas
granzym
b
gain
access
cleavag
site
observ
may
explain
find
highli
charg
ntermin
peptid
sequest
zymogen
cytosol
locat
inaccess
activ
initi
ident
factor
interact
establish
high
degre
sequenc
ident
catalyt
domain
figur
strongli
suggest
major
featur
inact
zymogen
mechan
activ
describ
also
essenti
valid
two
caspas
importantli
residu
line
central
caviti
intersubunit
linker
intrud
caviti
conserv
conserv
replac
eg
strictli
conserv
conserv
replac
alanin
thu
may
expect
substratebind
loop
also
disord
due
partial
insert
intersubunit
linker
central
caviti
might
howev
differ
degre
linker
insert
possess
alanin
residu
posit
would
allevi
steric
clash
elbow
loop
linker
peptid
notwithstand
biochem
investig
confirm
valid
model
includ
chang
environ
upon
proteolyt
activ
also
support
model
constitut
activ
recombin
gener
exchang
order
larg
small
subunit
express
construct
addit
eleg
experi
mixtur
separ
express
subunit
allow
refold
also
form
activ
enzym
spontan
eg
see
final
stress
cleavag
intersubunit
linker
essenti
element
activ
process
appear
limit
effector
caspas
eukaryot
haemoglobinas
gingipain
r
close
relat
clan
cd
proteas
structur
inform
exist
analysi
activ
process
report
cleavag
intersubunit
linker
requir
activ
gingipain
r
addit
report
autocatalyt
process
site
human
separas
preced
cystein
proteas
domain
sinc
activ
form
caspas
seen
crystal
structur
contain
larg
small
subunit
compris
catalyt
domain
assum
caspas
activ
proteolyt
cleavag
within
linker
region
review
howev
recent
studi
reveal
cleavag
neither
requir
suffici
activ
initi
activ
mechan
reli
previous
unappreci
properti
resid
latent
state
monom
requir
dimer
assum
activ
conform
properti
demonstr
recombin
materi
natur
endogen
zymogen
stark
contrast
zymogen
effector
alreadi
dimer
latent
form
reason
import
differ
first
glanc
incongru
clarifi
evolutionari
point
view
cofactormedi
oligomer
constitut
primordi
mechan
procaspas
activ
exemplifi
c
elegan
caspas
cell
deathdefect
apoptot
proteas
activ
orthologu
natur
activ
mechan
puzzl
research
particular
follow
realiz
caspas
activ
order
cascad
activ
initi
caspas
process
zymogen
effector
enzym
reason
clear
proteolyt
enzym
upstream
initi
caspas
thu
appar
zymogen
must
possess
certain
degre
latent
activ
suggest
label
singlechain
use
rel
high
concentr
biotinyl
methyl
keton
inhibitor
quantit
initi
caspas
show
low
zymogen
ie
ratio
activ
cleav
compar
uncleav
form
valu
contrast
valu
mean
initi
caspas
zymogen
much
greater
tendenc
becom
activ
effector
zymogen
featur
share
mechanist
unrel
serin
proteas
blood
clot
fibrinolyt
cascad
also
proceed
sequenti
activ
inact
proform
particular
upstream
factor
latter
cascad
tissuetyp
plasminogen
activ
possess
similar
zymogen
physiolog
activ
plasminogen
activ
depend
upon
coloc
fibrin
clot
similar
manner
initi
coagul
cascad
factor
viia
process
substrat
factor
x
bound
cofactor
tissu
factor
set
initi
procaspas
apart
upstream
serin
proteas
enforc
oligomer
natur
cofactorinduc
chimaer
variant
result
activ
strike
contrast
effector
caspas
activ
initi
caspas
requir
process
intersubunit
linker
cleavag
may
simpli
provid
stabil
activ
dimer
summari
oligomer
inflammatori
initi
procaspas
suffic
trigger
process
constitut
central
postul
induc
proxim
model
discuss
accumul
structur
biochem
evid
support
mechan
recal
oligomer
event
occur
vivo
multiprotein
activ
complex
activ
platform
engag
caspas
zymogen
virtu
ntermin
card
ded
recruit
domain
activ
complex
involv
depend
origin
death
stimulu
either
extrins
disc
deathinduc
signal
complex
intrins
apoptosom
figur
supplement
figur
http
crystal
structur
card
complex
card
reveal
complex
format
mediat
exquisit
balanc
complementari
charg
surfac
two
modul
structur
correspond
ded
ded
dd
dd
complex
constitut
disc
unknown
date
isol
domain
report
along
extens
mutagenesi
studi
addit
structur
heterodim
form
dd
modul
drosophila
kinas
pell
adaptor
tube
repres
valuabl
templat
relat
fa
fadd
fa
tnf
receptor
associ
via
death
domain
complex
critic
reassess
structur
mutagenesi
evid
allow
recent
develop
work
model
disc
featur
threecorn
aggreg
centr
either
trimer
fa
dd
fadd
dd
modul
similar
arrang
propos
heterohexamer
complex
fadd
ded
modul
although
dedscard
catalyt
domain
procaspas
separ
rel
long
linker
figur
appar
product
encount
two
zymogen
monom
would
facilit
enorm
prodomainmedi
recruit
adaptor
platform
would
convert
bimolecular
interact
rel
weak
k
much
product
unimolecular
reaction
event
concomit
dimer
appear
understand
major
question
remain
unansw
dimer
effector
procaspas
persist
dormant
state
dimer
initi
procaspas
form
either
fulli
activ
least
activ
enough
catalys
matur
locat
intersubunit
linker
correl
activ
pro
linker
insert
substratebind
site
disord
linker
expos
substratebind
site
form
observ
immedi
suggest
gener
central
caviti
access
linker
may
also
allow
least
transient
format
stabl
catalyt
machineri
independ
linker
cleavag
inde
crystal
structur
reveal
uniqu
insert
figur
two
monom
intrud
central
caviti
stabil
import
contact
figur
supplement
figur
http
hydrophob
contact
across
dimer
interfac
prime
transloc
allimport
adopt
activ
substratebind
conform
without
need
intersubunit
cleavag
hydrophob
interact
would
expect
stabil
activ
conform
uncleav
place
loop
bundl
process
effector
enzym
independ
crystal
structur
unusu
contain
one
catalyt
domain
activ
conform
one
zymogenlik
conform
b
pdb
code
loop
display
signific
chang
two
form
colour
red
blue
green
intersubunit
linker
figur
c
ribbon
plot
show
closeup
central
caviti
human
uniqu
insert
see
also
figur
monom
intrud
central
caviti
stabil
import
contact
addit
two
aliphat
residu
line
central
caviti
replac
bulkier
aromat
side
chain
initi
caspas
thu
effect
seal
central
caviti
wellconserv
whose
guanidinium
group
sandwich
activ
substitut
glycin
leav
addit
empti
space
elbow
loop
notabl
hydrophob
pocket
form
residu
seal
central
caviti
ie
togeth
accept
phenyl
moieti
elbow
loop
residu
neighbour
monom
thu
anchor
central
caviti
manner
residu
one
monom
indirectli
prime
neighbour
molecul
adopt
activ
substratebind
conform
without
need
intersubunit
cleavag
format
inde
uncleav
either
process
site
mutat
alanin
still
recruit
activ
within
reconstitut
apoptosom
vitro
uncleav
develop
activ
small
synthet
substrat
indistinguish
wild
type
mutagenesi
studi
underscor
critic
role
zymogen
dimer
activ
point
mutant
interfac
residu
ie
asp
val
doubl
mutant
asp
report
convincingli
replac
hydrophob
valin
compromis
induct
cell
death
mutant
asp
fail
trigger
activ
apoptosi
block
apoptosi
induc
overexpress
bax
furthermor
doubl
mutant
revers
charg
posit
fail
selfassoci
activ
fail
induc
cell
death
transfect
hela
cell
observ
explain
fact
electrostat
repuls
equal
charg
group
domain
interfac
would
impair
dimer
less
straightforward
ration
effect
mutat
aim
disrupt
loop
bundl
ie
ala
ala
alter
structur
protein
differ
significantli
monom
uncleav
dimer
fulli
process
dimer
mutant
report
low
level
activ
doubl
mutant
show
deficit
reversalofcharg
variant
notic
import
polarvan
der
waal
contact
made
cleav
dimer
predict
form
dimer
uncleav
molecul
mutant
might
simpli
add
relev
dimer
activ
howev
caution
must
use
interpret
consequ
mutat
caspas
dimer
interfac
sinc
unexpect
tendenc
substitut
compens
unanticip
interact
thu
multiplesit
mutant
interfac
produc
reason
function
dimer
enzym
probabl
explain
inher
strong
interfac
effector
caspas
compar
initi
caspas
mutat
simpli
suffici
radic
disrupt
dimer
importantli
steric
clash
dimer
interfac
prohibit
two
elbow
loop
occupi
central
caviti
simultan
line
observ
half
monom
label
valalaaspfluoromethyl
keton
solut
crystal
structur
human
confirm
unanticip
find
featur
second
domain
zymogenlik
conform
disabl
specif
determin
catalyt
apparatu
figur
supplement
movi
http
conform
inact
domain
almost
ident
zymogen
form
describ
find
suggest
might
two
major
mutual
exclus
conform
linkersubstr
bind
loop
supplement
movi
http
central
compon
apoptosom
protein
known
recruit
via
ntermin
card
quiescent
state
compact
molecul
head
card
tuck
feet
two
form
set
repeat
cytochrom
c
conveni
size
card
displac
head
allow
compact
structur
stretch
linear
molecul
polymer
upon
bind
atp
electron
cryomicroscopi
studi
show
apoptosom
sevenspok
wheel
central
hub
contain
recruit
domain
provid
card
interestingli
induc
stack
ring
densiti
assign
fulllength
electron
micrograph
apoptosom
complex
resembl
tetramer
arrang
domain
crystal
structur
cardless
figur
centr
interfac
two
activ
domain
top
figur
occupi
antiparallel
arrang
ctermini
card
larg
subunit
linker
includ
helic
stabil
strong
salt
bridg
side
chain
residu
conserv
differ
speci
ie
contact
inact
monom
mostli
mediat
expos
lean
neighbour
helix
form
import
van
der
waal
interact
notabl
edgetoedg
contact
two
indol
ring
well
polar
bond
eg
hydrogen
bond
indol
nitrogen
atom
altogeth
protect
surfac
dimerdim
interfac
area
dimer
particularli
larg
presenc
conserv
trp
arg
residu
point
biolog
relev
role
also
suggest
observ
chargerevers
variant
ly
behav
like
interfac
mutant
discuss
addit
phosphoryl
interfac
residu
figur
serthr
protein
kinas
aktprotein
kinas
b
also
inhibit
process
also
observ
phosphoryl
card
larg
subunit
linker
inhibit
process
vivo
vitro
mutat
glu
mimic
phosphoryl
threonin
side
chain
ala
reduc
activ
constitut
activ
variant
vitro
find
point
import
electrostat
interact
linker
within
apoptosom
conceiv
either
linker
two
procaspas
molecul
symmetr
approach
sandwich
globular
card
catalyt
domain
apoptosom
therefor
tempt
specul
domain
arrang
crystal
mimic
function
apoptosom
assembl
restrict
orient
card
catalyt
domain
might
help
dock
incom
substrat
molecul
regardless
combin
structur
biochem
evid
suggest
halfofsit
reactiv
biolog
relev
featur
flipflop
mechan
vivo
conceiv
upper
lower
monom
figur
chang
synchron
activ
inact
state
crystal
structur
procaspas
yet
report
howev
possibl
extend
model
activ
discuss
initi
extrins
apoptot
pathway
thank
larg
bodi
evid
accumul
multipl
biochem
biophys
studi
current
evid
indic
molecul
exist
inact
monom
solut
enhanc
oligomer
close
cell
membran
allow
transient
stabil
activ
conform
vivo
accordingli
dimer
interfac
mutant
asp
fail
induc
apoptosi
upon
fa
ligat
transfect
differ
cell
line
wherea
conserv
mutat
ser
even
enhanc
caspas
activ
gener
via
extrins
pathway
similarli
reversalofcharg
mutant
asp
ly
asp
show
sever
decreas
potenti
homodimer
vitro
process
upon
enforc
dimer
ntermin
f
v
domain
fulllength
form
contain
mutat
fail
induc
apoptosi
upon
fa
engag
result
obtain
latter
mutant
howev
view
caution
side
chain
point
directli
dimer
interfac
addit
carboxyl
hydrogenbond
mainchain
n
atom
final
also
underscor
similar
activ
mechan
cleavag
intersubunit
linker
requir
activ
neither
process
intersubunit
linker
follow
activ
exampl
doubl
mutant
ala
abrog
cell
death
transfect
experi
intrins
dimer
variant
furthermor
mutat
incorpor
prodomainless
form
still
display
activ
matur
would
loop
conform
dimer
compar
correspond
zymogen
observ
higher
zymogen
indic
insert
elbow
loop
central
caviti
favour
uncleav
word
equilibrium
displac
toward
linker
substratebind
loop
state
absenc
found
presenc
thr
residu
posit
figur
supplement
figur
http
wwwbiochemjorgbj
appear
mainli
respons
featur
remark
central
caviti
deeper
caspas
see
also
figur
increas
size
intermonom
space
might
allevi
steric
clash
linker
elbow
loop
furthermor
side
chain
intrud
central
caviti
hydrogenbond
mainchain
n
atom
respect
overal
result
similar
radic
replac
highli
conserv
glycin
liber
space
central
caviti
allow
transient
insert
elbow
loop
without
previou
proteolyt
cleavag
linker
peptid
nonenzym
homologu
cflip
l
flip
flice
faddlik
ice
inhibitori
protein
figur
recent
identifi
activ
extrins
pathway
lend
addit
support
induc
proxim
model
cofactorinduc
activ
also
ad
new
level
complex
activationmatur
process
vivo
initi
studi
alreadi
indic
cflip
l
overexpress
result
spontan
cell
death
cflip
l
knockout
mice
show
phenotyp
strikingli
similar
fadd
anim
nevertheless
cflip
l
long
consid
bona
fide
inhibitor
disc
format
recent
result
correct
view
indic
cflip
l
recruit
preferenti
disc
subsequ
heterodimer
molecul
induc
activesit
format
latter
without
sever
intersubunit
linker
inde
least
vitro
cflip
l
lower
barrier
heterodimer
lead
full
activ
appar
differ
inher
substrat
specif
homodimer
cflip
l
residu
figur
perhap
along
triplet
would
occlud
central
caviti
cflip
l
heterodim
disfavour
insert
linker
peptid
central
caviti
greater
extent
homodimer
therefor
predict
elbow
loop
molecul
heterodim
cflip
l
intrud
preferenti
central
caviti
gener
form
higher
intrins
activ
homodim
effect
ignit
extrins
apoptot
pathway
discuss
consequ
differenti
recruit
cflip
l
disc
absenc
structur
inform
conform
monomer
cytosol
remain
specul
associ
chaperon
protein
appear
attract
possibl
report
date
cognat
iap
known
contrast
control
xiap
see
posit
note
protein
term
carp
caspaseassoci
ring
realli
interest
new
gene
protein
suspect
regul
level
ubiquitinmedi
proteasom
degrad
although
mechan
report
altern
conceiv
either
intersubunit
linker
andor
ntermin
ded
block
dimer
interfac
small
subunit
thu
avoid
unregul
activ
vivo
regard
noteworthi
ntermin
extend
variant
possess
enhanc
dimer
potenti
solut
autoactiv
spontan
final
natur
truncat
form
lack
catalyt
domain
recruit
effici
disc
act
potent
inhibitor
apoptosi
even
rel
low
concentr
compar
fulllength
variant
also
suggest
fulllength
exist
somehow
close
conform
less
access
ded
beyond
activ
process
initi
caspas
matur
form
state
mechanist
point
view
proteolysi
inflammatori
initi
procaspas
constitut
epiphenomenon
need
gener
activ
enzym
howev
within
physiolog
activ
complex
also
supraphysiolog
concentr
achiev
overexpress
experi
intersubunit
andor
prodomain
larg
subunit
linker
cleav
rapidli
specif
aspart
residu
figur
least
former
cleavag
confer
addit
stabil
caspas
dimer
format
loop
bundl
noteworthi
cleavag
intersubunit
linker
site
repres
mean
inactiv
via
bind
xiap
see
two
question
aris
connect
mechan
proteolyt
matur
initiatorinflammatori
caspas
first
activ
procaspas
respons
cleavag
vivo
word
cleavag
perform
transient
activ
molecul
noncoval
bound
partner
intradim
mechan
adjac
dimer
interdim
mechan
furthermor
cleavag
proceed
sequenti
manner
first
intersubunit
prodomain
larg
subunit
linker
releas
inact
form
avoid
pose
second
challeng
sequenti
process
regul
access
cleavag
site
sequenti
access
model
intermedi
form
cleav
linker
specif
recogn
ntermin
site
sequenti
activ
model
model
answer
question
account
also
appar
paradox
matur
initi
caspas
abl
process
proform
vivo
import
open
question
recent
address
matur
intradim
mechan
favour
one
studi
suggest
intramolecular
process
initi
matur
step
ie
activ
molecul
cleav
linker
contrast
anoth
studi
present
evid
support
interdim
sequenti
access
mechan
matur
inspect
model
develop
base
zymogen
indic
major
structur
rearrang
would
need
intersubunit
linker
bind
product
activesit
cleft
bind
distant
activ
site
second
domain
practic
exclud
furthermor
propos
interdim
mechan
seem
better
captur
actual
activ
event
vivo
analysi
includ
fulllength
dedcontain
variant
process
purifi
disc
find
val
mutant
fail
process
although
possess
enzym
activ
upon
dimer
might
relat
disrupt
preloop
bundl
impair
conform
intersubunit
linker
interdim
mechan
matur
offer
among
advantag
eleg
explan
appar
mismatch
number
bind
site
singl
fa
fadd
complex
compos
three
molecul
dimer
natur
activ
pro
caspas
inde
third
lone
molecul
bound
fasfadd
heterotrim
would
posit
dimer
second
unmatch
monom
neighbour
disc
supplement
figur
http
www
interact
might
strengthen
aggreg
membraneproxim
fa
dd
fadd
dd
modul
perhap
also
contact
ctermin
ded
neighbour
molecul
support
model
come
observ
cluster
death
receptor
complex
enhanc
apoptosi
furthermor
model
immedi
suggest
interest
possibl
regul
cell
respons
extracellular
stimuli
exampl
allow
altern
onset
either
apoptosi
high
level
receptor
oligomer
concomit
gener
matur
prolif
pathway
small
proport
fa
molecul
engag
activ
follow
massiv
releas
matur
heterotetram
final
notic
presenc
five
differ
activ
isoform
differ
length
linker
along
cflip
variant
would
suggest
impress
rich
possibl
disc
arrang
engag
catalyt
inact
cflip
l
add
level
complex
initi
cours
death
receptor
pathway
cflip
l
complex
preferenti
process
local
substrat
rip
receptorinteract
protein
may
stimul
cell
surviv
pathway
via
activ
nuclear
propos
line
earli
observ
overexpress
intrins
dimer
form
matur
site
mutat
alanin
induc
cell
death
howev
odd
find
cleavag
rip
promot
apoptosi
enhanc
recruit
fadd
tradd
tnf
receptorassoci
death
domain
protein
concomit
activ
substrat
cflip
l
enrich
disc
pathway
stimul
preferenti
activ
membranerestrict
remain
elucid
postul
mechan
similar
one
discuss
activationmatur
also
captur
gener
featur
process
inflammatori
initi
procaspas
differ
briefli
discuss
somewhat
iron
mechan
activ
first
member
caspas
famili
identifi
character
crystallograph
less
intens
studi
oligomer
need
activ
impli
crystal
structur
initi
mutagenesi
studi
rigor
demonstr
soon
afterward
furthermor
observ
longprodomain
caspas
overexpress
refold
denatur
condit
result
spontan
autoactiv
requir
presenc
ntermin
card
semin
work
yamin
colleagu
show
extrem
low
detect
intrins
activ
also
detect
other
form
cleav
card
larg
subunit
linker
possess
moder
full
activ
respect
thu
principl
govern
activ
initi
seem
appli
inflammatori
caspas
possess
addit
residu
strand
also
conserv
figur
bulg
reduc
size
central
caviti
guanidinium
group
part
extend
hydrogenbondsaltbridg
network
across
central
caviti
includ
two
arginin
residu
carboxyl
along
carboxyamid
supplement
figur
http
www
thu
polarcharg
side
chain
occlud
central
caviti
pro
presum
also
stark
contrast
aromatichydrophob
natur
topolog
equival
residu
pro
conceiv
network
form
upon
dimer
molecul
thu
displac
intersubunit
linker
central
caviti
event
would
depend
salt
concentr
ph
hydrophob
prime
pocket
presenc
ntermin
card
impli
adaptor
protein
structur
relat
recruit
promot
activ
induc
proxim
model
ser
thr
kinas
riplik
interact
clarp
caspaselik
apoptosisregulatori
protein
kinasecardcontain
iceassoci
kinas
contain
ctermin
card
first
adaptor
report
bind
specif
card
direct
involv
activ
howev
question
shown
recent
kinas
play
critic
role
innat
adapt
immunorespons
includ
tcell
differenti
via
pathway
involv
activ
downstream
sever
tlr
tolllik
receptor
nod
nucleotidebind
oligomer
domaincontain
protein
second
put
adaptor
protein
iceproteaseactiv
factorcard
lrr
nachtcontain
protein
associ
specif
via
ntermin
card
induc
autocatalyt
process
inflammatori
caspas
ipaf
contain
addit
nbd
nucleotidebind
domain
lrr
motif
oligomer
carddepend
manner
suggest
format
apoptosomelik
structur
appear
critic
transmit
activ
induc
macrophag
infect
salmonella
typhimurium
lipopolysaccharid
actual
activationmatur
process
vivo
may
complic
howev
recent
investig
coactiv
preferenti
within
larg
macromolecular
complex
organ
around
two
adaptor
protein
asc
pycard
apoptosisassoci
specklik
protein
contain
cardpydand
cardcontain
molecul
term
inflammasom
asc
requir
effici
activ
follow
either
typhimurium
infect
lipopolysaccharid
indic
ipaf
overlap
nonident
role
host
inflammatori
respons
pathogen
mechan
conceptu
similar
extrins
pathway
deliveri
lipopolysaccharid
promot
adaptor
heterodimer
associ
ntermin
pyrin
domain
allow
ctermin
card
interact
specif
homolog
domain
respect
activ
caspas
zymogen
occur
via
induc
proxim
mechan
activ
procaspas
abl
process
intersubunit
linker
occur
presum
via
interdim
cleavag
overexpress
result
autoactiv
strict
carddepend
manner
vivo
pyrin
domain
asc
seem
respons
oligomer
molecul
addit
matur
card
larg
subunit
site
depend
upon
presenc
complementari
procaspas
support
model
mous
orthologu
human
indispens
gener
activ
mice
physic
interact
addit
ser
variant
convert
matur
form
coexpress
co
cell
whether
adaptor
molecul
discuss
repres
complementari
concurr
pathway
vivo
depend
cell
type
apoptoticinflammatori
stimulu
remain
clarifi
interestingli
activ
cleav
detect
extracellular
medium
extern
mechan
remain
uncharacter
also
current
unknown
inflammatori
signal
transmit
trigger
assembl
inflammasom
author
suggest
lrr
domain
may
recogn
pathogenassoci
molecular
pattern
andor
endogen
alarm
signal
perhap
analog
cytochrom
c
bind
propel
apoptosom
circumstanti
support
hypothesi
come
exist
larg
famili
intracellular
protein
member
human
recent
review
may
account
differenti
recognit
specif
pathogenspecif
marker
andor
second
messeng
presenc
thu
might
structur
coincid
motif
use
tlr
plant
diseaseresist
protein
recognit
pathogenassoci
molecular
pattern
extracellular
environ
also
present
relat
adaptor
recent
work
suggest
inde
lrr
anoth
famili
member
recogn
bacteri
muramyl
dipeptid
pathway
perhap
best
appreci
light
interplay
bacteri
factor
host
cell
deathinflammatori
respons
instanc
bifurc
mechan
downstream
engag
bacteri
lipoprotein
either
stimul
activ
apoptosi
proinflammatori
respons
activ
process
promot
activ
cell
surviv
see
eg
similarli
lipopolysaccharid
promot
fadddepend
cell
death
endotheli
monocyt
cell
upon
bind
also
trigger
caspas
activ
dendrit
cell
critic
surviv
matur
final
sever
bacteri
pathogen
modul
apoptot
differenti
programm
human
neutrophil
one
gene
upregul
follow
phagocytosi
repress
understand
interplay
inflammatori
apoptot
respons
elicit
resolv
pathogen
infect
mechan
use
pathogen
evad
andor
subvert
pathway
like
contribut
import
insight
infect
process
clearanc
obviou
potenti
clinic
applic
interest
topic
howev
outsid
realm
review
although
absenc
sever
abnorm
mice
point
less
import
role
cell
death
cardcontain
caspas
suggest
act
upstream
mitochondria
within
intrins
apoptot
pathway
appear
necessari
particular
onset
apoptosi
upon
sever
insult
includ
uv
irradi
treatment
dnadamag
agent
etoposid
cisplatin
ident
direct
mitochondri
target
disput
releas
cytochrom
c
intermembran
space
among
proapoptot
factor
seem
requir
bid
cleavag
recent
identif
histon
cytochrom
creleas
factor
follow
dna
doublestrand
break
suggest
perhap
also
nuclear
substrat
might
involv
membran
permeabil
adaptor
involv
activ
also
subject
controversi
zymogen
recruit
cardcontain
protein
craddraidd
domaincontain
adaptor
death
domainripassoci
protein
death
domain
coupl
tnf
receptor
signal
complex
via
two
adaptor
protein
rip
tradd
complex
format
craddraidd
probabl
mediat
similar
electrostat
interact
ntermin
card
craddraidd
demonstr
complex
howev
sinc
appear
irrelev
receptormedi
apoptosi
independ
pathway
directli
coupl
genotox
stress
activ
may
expect
pathway
may
requir
assembl
larg
adaptor
platform
recent
evid
suggest
adaptor
pidd
protein
death
domain
collabor
raidd
activ
complex
sinc
pidd
origin
identifi
gene
like
complex
assembl
pidd
would
initi
apoptosi
follow
dna
damag
contrast
suppress
use
rna
interfer
found
inhibit
extrins
pathway
trigger
trail
tnfrelat
apoptosisinduc
ligand
via
pathway
suggest
role
cleavag
bid
addit
role
process
catalyt
inact
releas
cytochrom
c
mitochondria
spice
mix
report
function
fascin
caspas
endogen
zymogen
overexpress
form
found
constitut
cell
nucleu
see
eg
nuclear
local
signal
flank
card
respons
uniqu
featur
particular
conserv
motif
mediat
interact
importin
heterodim
contrast
caspas
crystal
structur
reveal
intrins
coval
dimer
oppos
central
residu
strand
form
interdomain
disulphid
bond
supplement
figur
http
coval
linkag
appear
rather
stabl
reduc
agent
use
throughout
protein
purif
crystal
furthermor
disrupt
separ
larg
small
subunit
reversephas
chromatographi
howev
cytosol
found
monom
cytosol
transfect
cell
tempt
specul
repres
evolutionari
link
origin
intrins
dimer
caspas
requir
oligomer
activ
current
member
famili
along
line
card
might
close
relat
primordi
dd
subfamili
evolv
also
indic
presenc
c
elegan
wide
appreci
endogen
inhibitor
strictli
regul
activ
matur
caspas
vivo
surprisingli
view
critic
role
immun
respons
eventu
clear
viral
infect
cell
sever
viral
inhibitor
also
target
host
caspas
instanc
sever
herpesvirus
tumorigen
molluscipoxviru
block
extrins
pathway
level
zymogen
recruit
disc
help
decoy
molecul
vflip
inhibitor
essenti
compos
one
two
copi
domain
similar
dd
endogen
protein
preferenti
interact
adaptor
protein
fadd
interrupt
assembl
function
disc
similar
strategi
employ
endogen
inhibitor
cflip
compet
recruit
disc
well
cardcontain
inhibitor
iceberg
start
section
brief
discuss
two
viral
activesitedirect
inhibitor
serpin
crma
cytokin
respons
modifi
cowpox
viru
baculoviru
inhibitor
final
discuss
recent
advanc
understand
mechan
caspas
inhibit
major
cellular
inhibitor
iap
natur
inhibitor
proteolyt
enzym
directli
block
substrat
access
activ
site
cognat
proteas
usual
employ
substratelik
sequenc
specif
bait
reveal
sever
crystal
structur
stabl
enzymeinhibitor
complex
form
without
gross
structur
distort
either
moieti
review
contrast
biolog
import
natur
inhibitor
collect
term
suicid
inhibitor
mechanismbas
inactiv
cleavag
bait
follow
major
structur
rearrang
inhibitor
andor
cognat
proteas
two
viral
inhibitor
discuss
although
otherwis
complet
unrel
sequenc
structur
mechanist
relat
member
class
briefli
discuss
main
featur
caspas
inhibit
crma
review
detail
elsewher
serpin
form
widespread
superfamili
larg
inhibitor
amino
acid
residu
employ
uniqu
suicid
mechan
inactiv
target
proteas
recent
review
see
inhibitor
initi
form
noncoval
micha
complex
proteas
interact
expos
loop
well
understood
case
serin
proteas
inhibit
attack
activesit
p
p
scissil
bond
concomit
format
coval
ester
linkag
atom
backbon
carbonyl
p
residu
proceed
normal
catalysi
subsequ
cleavag
peptid
bond
howev
follow
rapid
insert
ntermin
part
loop
main
bodi
serpin
synchron
displac
coval
bound
proteas
opposit
pole
inhibitor
crystal
structur
antitrypsintrypsin
complex
show
serin
proteas
inhibit
result
clash
loop
surround
activ
site
enzym
main
bodi
serpin
loop
therebi
disord
catalyt
residu
separ
approx
serpin
act
almost
proteas
denatur
although
known
serpin
specif
serin
proteas
crossclass
inhibitor
also
known
serpin
cowpox
viru
crma
inhibit
cytotox
serin
proteas
granzym
b
also
k
valu
nm
respect
serpin
also
inhibit
vitro
yet
fail
block
cell
death
two
independ
solv
crystal
structur
cleav
crma
show
viral
serpin
possess
common
structur
featur
found
member
superfamili
studi
date
crma
howev
constitut
minim
serpin
lack
complet
helix
arrow
sequenc
indic
bind
revers
mode
effector
caspas
see
text
figur
caspas
cleavag
site
xiap
indic
cleavag
also
detect
b
cartoon
depict
mode
bind
caspas
larg
subunit
blue
small
subunit
red
bound
respect
bir
orang
shallow
groov
bir
domain
symbol
smac
pocket
four
ntermin
residu
constitut
iapbind
motif
fit
although
import
inhibit
signific
groov
less
well
understood
term
inhibit
c
ribbon
diagram
inhibitori
interact
colour
code
nand
ctermini
subunit
complex
label
import
side
chain
interact
shown
simplic
label
mammalian
member
superfamili
contribut
alloster
activ
regul
addit
helic
also
shorten
compar
mammalian
serpin
capabl
serpin
target
caspas
extend
least
vitro
endogen
serpin
well
instanc
physiolog
inhibitor
granzym
b
proteas
could
transform
potent
caspas
inhibitor
abl
block
fasmedi
apoptosi
simpli
mutat
p
residu
glutam
aspart
experiment
proof
similar
mechan
serpinmedi
inhibit
compress
caspas
lack
yet
gettin
discuss
possibl
detail
conclud
cystein
proteas
fulfil
major
prerequisit
inhibit
accord
standard
suicid
mechan
exampl
activ
site
access
thioester
linkag
stabl
proteas
may
pull
bottom
serpin
upon
cleavag
p
p
scissil
bond
nevertheless
studi
certainli
need
establish
gener
valid
mechan
attract
hypothesi
transloc
coval
bound
caspas
forc
expuls
substrat
bind
loop
observ
caspas
zymogen
see
baculoviru
protein
known
natur
inhibitor
target
caspas
inhibit
granzym
b
crystal
structur
free
complex
human
togeth
recent
investig
sitedirect
mutagenesi
reveal
previous
unobserv
mechan
inhibit
refer
bowstr
model
engag
caspaserecognit
sequenc
within
protrud
loop
follow
format
thioester
linkag
catalyt
carbonyl
p
residu
cleavag
scissil
peptid
bond
howev
lead
reposit
nterminu
close
activ
site
bound
caspas
prevent
access
hydrolyt
water
molecul
catalyt
residu
consequ
avoid
deacyl
thioester
bond
mechan
inhibit
present
analog
serpin
intermedi
peptid
hydrolysi
remain
kinet
trap
complex
disabl
enzym
restructur
inhibitor
cleavag
bait
loop
howev
structur
essenti
unaffect
compar
extens
unfold
serpininhibit
trypsinlik
proteas
baculovir
homologu
known
inhibit
initi
caspas
insect
sf
caspasex
well
human
vitro
interestingli
repres
first
exampl
caspas
inhibitor
appear
interact
region
distant
activ
site
exosit
modul
caspas
specif
inde
swap
caspas
target
sequenc
residu
posit
p
p
chang
specif
chimaer
variant
author
conclud
structur
determin
respons
restrict
specif
initi
caspas
particular
insert
domain
locat
ctermin
p
site
residu
interestingli
contrast
widespread
distribut
serpin
homologu
identifi
date
anim
studi
regul
insect
cell
death
induc
baculoviru
lack
function
gene
led
discoveri
anoth
potent
inhibitor
apoptosi
iap
protein
character
small
residu
highli
conserv
zn
bind
modul
term
bir
baculovir
iap
repeat
endogen
homologu
iap
identifi
shortli
afterward
anim
eight
member
character
date
human
review
current
evid
indic
endogen
iap
one
import
control
point
control
point
apoptosi
execut
effect
counteract
low
amount
adventiti
activ
caspas
perhap
importantli
establish
threshold
extens
caspas
gener
rapidli
occur
caspasedepend
independ
antiapoptot
activ
iap
report
review
caspaseindepend
antiapoptot
mechan
found
howev
pathway
poorli
understood
yet
consequ
shall
concentr
review
paradigm
human
iap
xiap
avail
crystal
structur
show
constitu
domain
bound
differ
caspas
iap
regul
allow
understand
direct
effect
apoptosi
see
figur
schemat
represent
xiap
domain
organ
structur
investig
turn
follow
biochem
studi
map
caspasebind
site
xiap
thu
fragment
compris
domain
linker
ntermin
modul
target
effector
hand
tandem
specif
inhibit
activ
depend
almost
exclus
domain
complet
unrel
mechan
caspas
inhibit
employ
two
xiap
subunit
discuss
crystal
structur
bound
minimum
caspaseinhibit
region
xiap
report
see
figur
represent
xiap
complex
result
structur
investig
rather
unexpect
three
count
first
region
inhibitor
make
import
contact
enzym
correspond
linker
peptid
globular
bir
domain
agreement
previou
mutagenesi
studi
secondli
peptid
dock
revers
orient
caspas
activesit
cleft
relat
observ
bind
mode
product
bound
substrat
inhibitor
compar
figur
thirdli
particularli
remark
carbonyl
carbon
xiap
approach
catalyt
atom
closer
oxyanion
pocket
enzym
remain
unoccupi
xiap
exploit
peculiar
structur
engag
import
van
der
waal
interact
residu
insert
flap
notabl
aromat
side
chain
contact
inhibitor
wherea
interact
side
chain
critic
residu
well
manifold
interact
suggest
caspas
may
evolv
ensur
inhibit
iap
rather
mean
increas
substrat
select
addit
explain
xiap
target
activ
effector
caspas
bind
inact
zymogen
possess
disord
substratebind
loop
see
carboxyl
second
xiap
residu
critic
inhibit
occupi
pocket
enzym
although
revers
conform
linker
peptid
preclud
exact
mimick
substratelik
inhibitor
compar
figur
also
noteworthi
globular
bir
domain
defin
electron
densiti
xiap
structur
disord
independ
determin
complex
j
riedl
w
bode
g
salvesen
p
fuentesprior
unpublish
work
solventprotect
area
bir
domain
seem
small
support
format
stabl
interact
perhap
importantli
interfac
lack
conserv
hot
spot
residu
particular
trp
also
aromat
side
chain
phetyr
well
met
arg
defin
proteinprotein
interact
although
observ
suggest
minor
role
domain
caspas
inhibit
studi
truncat
variant
easili
reproduc
actual
situat
vivo
point
other
moreov
crystal
structur
xiap
complex
show
ntermin
residu
caspas
small
subunit
occupi
surfac
pocket
symmetryrel
inhibitor
molecul
engag
interact
close
resembl
seen
xiap
complex
see
togeth
find
suggest
interact
linker
activesit
cleft
activ
free
catalyt
site
red
pdb
bound
grey
pdb
highli
conserv
substanti
alter
mainchain
sidechain
conform
dock
cleft
tetrapeptid
cmk
inhibitor
bind
must
rotat
accept
p
side
chain
green
arrow
consequ
linker
region
appear
perfectli
adapt
unligand
activ
form
b
superposit
xiap
inhibitori
region
pink
stick
acetyldvadcmk
blue
stick
activesit
cleft
pdb
file
orient
figur
show
small
footprint
made
acetyldvadcmk
sidechain
cyan
compar
made
xiap
side
chain
magenta
note
manifold
interact
two
residu
linker
critic
activ
ie
former
engag
van
der
waal
contact
occupi
pocket
caspas
hydrogenbond
particular
residu
substratebind
loop
addit
carboxyl
clamp
ctermin
residu
xiap
shown
c
crystal
structur
green
bound
blue
taken
pdb
bir
domain
take
posit
dimer
partner
domain
essenti
monomer
caspas
thu
revers
process
zymogen
activ
blowup
depict
conform
relay
upon
bind
green
residu
forc
activ
conform
red
inact
one
blue
rotat
requir
compensatori
rotat
concomit
expuls
catalyt
noncatalyt
locat
e
footprint
residu
shade
magenta
contact
either
dimer
partner
e
dimer
interfac
note
although
contact
extens
dimer
crucial
contact
except
segment
form
ibm
interact
smac
pocket
render
pymol
grasp
electrostat
surfac
potenti
xiap
contour
k
b
e
stick
represent
neoepitop
gener
follow
cleavag
blue
pdb
superimpos
ntermin
tetrapeptid
matur
smacdiablo
orang
pdb
residu
identifi
correspond
colour
notic
highli
neg
end
smac
pocket
help
counter
energet
penalti
buri
posit
charg
ntermin
amin
ibm
peptid
tell
whole
stori
addit
strengthen
interact
seen
directli
crystal
structur
may
occur
solut
crystal
structur
xiap
complex
nice
explain
inhibitori
mechan
show
globular
bir
domain
bind
monom
manner
block
surfac
patch
correspond
intermonom
area
activ
caspas
dimer
see
figur
import
contact
interfac
includ
residu
uniqu
togeth
pair
phenyl
ring
occupi
central
caviti
dimer
see
also
figur
supplement
figur
http
moreov
ctermin
helic
two
moieti
align
antiparallel
manner
allow
side
chain
xiap
interdigit
neighbour
inhibitor
side
chain
engag
hydrogen
bond
mainchain
atom
caspas
multipl
interact
xiap
effect
counteract
dimer
concomit
activ
see
perhap
strike
interact
seen
ntermin
tetrapeptid
thrproph
small
subunit
groov
surfac
predict
figur
supplement
movi
http
www
groov
xiap
moieti
frequent
call
smac
second
mitochondri
activ
caspas
pocket
structur
equival
area
engag
ntermin
tetrapeptid
small
subunit
hint
conserv
mechan
howev
interact
much
direct
occur
within
molecul
inhibit
interact
vital
inhibitori
function
xiap
site
util
iap
antagonist
derepress
inhibit
see
mutat
xiap
side
chain
contact
ala
ser
ala
ala
gli
glu
ala
confirm
critic
role
inhibit
addit
investig
fulllength
xiap
molecul
incorpor
mutat
togeth
ala
corrobor
result
structur
investig
physiolog
frame
interestingli
substratebind
loop
xiap
bound
solventexpos
conform
almost
ident
inact
zymogenlik
monom
particular
conform
reproduc
inact
monom
stabil
similar
contact
neighbour
caspas
molecul
figur
also
expos
mobil
judg
hightemperatur
valu
find
indirectli
confirm
monomer
natur
zymogen
vivo
see
explain
rel
larg
hydrophob
patch
form
intermonom
region
protect
bulk
solvent
thu
avoid
unwant
dimer
activ
mode
bind
xiap
activ
dimer
remain
unresolv
either
differ
like
bind
first
free
nterminu
small
subunit
perhap
aid
monomer
essenc
revers
zymogen
activeenzym
transit
basi
conserv
mechan
one
might
expect
drosophila
equival
dronc
drosophila
caspas
inhibit
cognat
iap
similar
manner
xiap
howev
dronc
util
cleav
intersubunit
linker
bind
rather
segment
ntermin
caspas
catalyt
domain
nevertheless
bind
equival
smac
pocket
although
revers
orient
unexpect
find
suggest
smac
pocket
bir
domain
simpli
bind
specif
ntermini
protein
togeth
stand
xiap
retain
activ
bound
apoptosom
appar
singl
xiap
molecul
simultan
bind
inhibit
moieti
xiap
remain
bound
activ
within
apoptosom
enhanc
affin
xiap
suggest
tight
packag
activ
xiap
within
apoptosom
consid
larger
interfac
access
xiap
dimer
form
initi
caspas
compar
figur
sequest
activ
interact
linker
would
contribut
stabil
apoptosom
vivo
context
smac
pocket
domain
would
free
accept
ntermin
tetrapeptid
neighbour
small
subunit
observ
crystal
structur
xiap
complex
see
also
support
model
exercis
interact
might
explain
preserv
inhibitori
activ
xiap
cleav
also
note
xiap
interact
oligomer
domain
respons
interact
unknown
date
predict
domain
locat
ring
domain
figur
might
involv
adaptor
bind
mechanist
sens
situat
resembl
regul
blood
coagul
cascad
via
highli
specif
multidomain
inhibitor
tfpi
tissu
factor
pathway
inhibitor
similar
interact
xiap
initi
effector
caspas
one
tfpi
domain
block
upstream
factor
viia
equival
second
domain
target
activ
factor
xa
correspond
importantli
cascad
gener
small
amount
activ
downstream
proteas
requir
format
final
complex
larg
surfac
area
protect
xiap
interfac
would
suggest
synergist
bind
effect
block
apoptosomemedi
apoptosi
inde
current
evid
suggest
xiap
remov
caspas
complex
includ
proteolyt
degrad
apoptosi
progress
see
iap
clearli
function
addit
caspas
inhibit
found
organ
yeast
neither
contain
caspas
undergo
apoptosi
moreov
although
mechanist
studi
iap
relat
bind
direct
inhibit
caspas
catalyt
activ
like
iap
function
downregul
caspas
inhibit
act
ligas
rapid
remov
via
proteasom
rout
see
also
irrespect
actual
mechan
termin
caspas
activ
iap
set
scene
final
phase
caspas
control
derepress
iapinhibit
complex
method
caspas
activ
iapinteract
protein
first
identifi
drosophila
genet
screen
four
known
activ
apoptosi
fli
employ
iap
bind
rpr
grim
hid
heat
involut
defect
skl
encod
partial
redund
function
share
ntermin
amino
acid
motif
refer
ibm
iapbind
motif
detail
iapbind
protein
found
recent
review
keep
scope
review
focu
mainli
structur
consider
protein
liber
mitochondri
intermembran
space
mammal
signal
proapoptot
protein
play
role
derepress
caspas
inhibit
least
vitro
homodimer
smac
protein
also
known
mice
diablo
direct
iapbind
protein
low
pi
mammalian
multimer
serin
proteas
omi
thioredoxin
peroxidas
drosophila
common
otherwis
unrel
protein
presenc
similar
ntermin
tetrapeptid
sequenc
abl
antagon
inhibitori
action
xiap
tetrapeptid
sequenc
similar
neoepitop
gener
small
subunit
follow
proteolysi
figur
part
explain
derepress
inhibit
support
derepress
model
come
crystal
structur
smac
xiap
complex
solut
structur
domain
bound
smac
nterminu
structur
investig
reveal
ntermin
knob
occupi
smac
pocket
extend
conform
almost
ident
assum
ntermin
peptid
small
subunit
figur
supplement
movi
http
smac
establish
intric
network
hydrogen
bond
sever
side
chain
inhibitor
particular
importantli
second
interfac
two
elong
smac
helic
xiap
buri
addit
surfac
area
notabl
altern
splice
form
smac
lack
ntermin
knob
cytosol
smac
well
recombin
form
lack
first
residu
still
promot
apoptosi
vivo
extent
mitochondri
smac
discoveri
second
contact
interfac
would
help
explain
find
importantli
smac
displac
domain
complex
vitro
author
suggest
smac
bind
domain
may
affect
conform
linker
peptid
longer
bind
inhibit
altern
explan
nterminu
small
subunit
may
form
stabil
interact
smac
groov
much
seen
structur
destabil
smac
see
supplement
movi
http
howev
known
whether
smac
displac
fulllength
xiap
similar
complex
vivo
biochem
studi
smac
bind
perform
individu
bir
domain
xiap
demonstr
rel
weak
k
rang
nm
howev
recent
investig
demonstr
smac
bound
subnanomolar
affin
connect
domain
observ
demonstr
import
twosit
interact
competit
caspas
smac
underscor
likelihood
oligomer
protein
contain
ibm
derepress
caspas
activ
effici
vivo
hexamer
mitochondri
chaperonedegrad
proteas
contain
ibm
ntermini
like
recapitul
derepress
properti
smac
addit
physic
competit
xiap
bind
caspas
recent
shown
degrad
iap
vitro
activ
also
depend
ntermin
peptid
although
author
fail
detect
degrad
product
vivo
presum
target
degrad
proteasom
yang
cowork
demonstr
inactiv
rna
interfer
abolish
cleavag
cell
desensit
cell
apoptosi
induc
trail
proteas
cleav
instanc
within
linker
line
previou
find
kda
degrad
product
degrad
iap
either
andor
activ
caspas
observ
fasinduc
apoptosi
may
contribut
overcom
hurdl
pose
inhibitor
addit
cleavag
would
weaken
interact
xiap
thu
facilit
displac
inhibitor
via
smac
andor
bir
domain
xiap
appear
exclus
respons
direct
caspas
inhibitori
activ
ubiquitin
ligas
activ
demonstr
ring
domain
found
sever
member
famili
latter
seem
repres
addit
level
regul
apoptosi
two
altern
mutual
exclus
scenario
propos
autoubiquityl
iap
lead
subsequ
degrad
proteasom
ring
domain
modifi
iapbound
molecul
signal
degrad
iapmedi
ubiquityl
smacdiablo
ibmcontain
protein
tnf
receptorassoci
factor
report
ubiquityl
process
may
either
potenti
counteract
antiapoptot
potenti
iap
least
case
xiap
howev
major
effect
ubiquityl
vivo
appear
antiapoptot
comprehens
structur
basi
regul
apoptosi
quit
advanc
probabl
field
describ
signal
pathway
begin
end
know
fundament
structur
exampl
initi
phase
premitochondri
regul
phase
cover
review
effector
execut
phase
inhibitor
antagonist
even
structur
substrat
field
advanc
best
known
proteolyt
pathway
coagul
cascad
new
paradigm
initi
proteolyt
pathway
reveal
along
unexpect
way
util
interact
proteolyt
inhibit
howev
point
view
understand
mechan
remain
sever
import
gap
structur
biolog
solv
context
see
follow
challeng
futur
structur
determin
zymogen
initi
caspas
highresolut
imag
activ
platform
apoptosom
disc
inflammasom
identif
conform
requir
defin
natur
protein
caspasesubstr
recognit
site
elucid
threedimension
structur
compon
entir
apoptot
signal
pathway
perhap
primit
paradigm
c
elegan
scientist
involv
highthroughput
crystallographi
initi
promis
within
year
structur
determin
simpl
sequenc
dna
place
order
wait
coupl
week
result
although
may
bit
optimist
complex
assembl
bode
well
excit
next
year
current
hypothes
cell
decid
fate
proven
otherwis
thank
past
present
member
laboratori
insight
discuss
work
describ
support
nih
grant
